Researchers develop a potential IVIG replacement for treating autoimmunity that’s significantly more potent
The discovery could greatly improve patient experience and address supply shortages. Peer-Reviewed Publication Rockefeller University image: A histology showing the ankle joint of a mouse four days after receiving the new antibody treatment, V11 sFc. view more Credit: Ravetch lab at The Rockefeller University Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG […]
